Advisory Committee

Jeff Sharman, MD, is the Medical Director of Hematology Research at US Oncology, and the Director of Research at the Willamette Valley Center Institute in Eugene, Oregon. Dr. Sharman also helps to lead the Sarah Cannon Hematology program. He helped develop the science for B-cell receptor signal inhibitors. He has helped develop multiple BTK inhibitors, PI3K inhibitors, polatuzumab, venetoclax, obinutuzumab among others.

Dr. Sharman earned a medical degree from UC Davis in Davis, California. He completed a residency in internal medicine from Massachusetts General Hospital in Boston, Massachusetts, and a fellowship with Stanford University in Stanford, California. He earned a bachelor's degree in biochemistry from UC San Diego in San Diego, California.